The Babak Lab shared a post on LinkedIn:
“Scientific Wednesdays: TRBC1-Targeting ADCs for T-Cell Malignancies
A new Nature study introduces TRBC1-targeting antibody-drug conjugates (ADCs) as a precision strategy for treating…
Scientific Wednesdays: TRBC1-Targeting ADCs for T-Cell Malignancies – The Babak Lab
